-
Je něco špatně v tomto záznamu ?
Inhibition of transforming growth factor beta-1 augments liver regeneration after partial portal vein ligation in a porcine experimental model
V. Liska, V. Treska, H. Mirka, J. Kobr, R. Sykora, T. Skalicky, A. Sutnar, O. Vycital, J. Bruha, P. Pitule, A. Chlumska, J. Racek, J. Benes, L. Holubec,
Jazyk angličtina Země Řecko
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NS9731
MZ0
CEP - Centrální evidence projektů
PubMed
22251543
DOI
10.5754/hge10116
Knihovny.cz E-zdroje
- MeSH
- biologické markery metabolismus MeSH
- časové faktory MeSH
- hypertrofie MeSH
- játra krevní zásobení účinky léků metabolismus patologie MeSH
- ligace MeSH
- modely u zvířat MeSH
- monoklonální protilátky farmakologie MeSH
- novorozená zvířata MeSH
- prasata MeSH
- proliferace buněk účinky léků MeSH
- regenerace jater účinky léků MeSH
- transformující růstový faktor beta1 antagonisté a inhibitory metabolismus MeSH
- vena portae chirurgie MeSH
- zvířata MeSH
- Check Tag
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
BACKGROUND/AIMS: TGF-β1 is a pleiotropic cytokine that is over expressed in terminal phase of liver regeneration. METHODOLOGY: Twenty-four hours after partial portal vein ligation monoclonal antibody against TGF-β1 (TGF-β1 group, 7 piglets) or physiological solution (control group, 9 piglets) were applied into the central venous catheter. The biochemical parameters (bilirubin, urea, creatinine, alkaline phosphatase, gamma- glutamyl transferase, cholinesterase, aspartate aminotransferase, alanine aminotransferase and albumin) were assessed. The compensatory hypertrophy of the non-occluded liver lobes was evaluated by periodic ultrasonography during the next fourteen days and by histological examination. RESULTS: The acceleration of growth of the hypertrophic liver lobes was maximal between 3rd and 7th postoperative days in comparison with the control group (p<0.05). No important differences in the biochemical or studied histological parameters were proved. CONCLUSIONS: The present study describes a new usage of monoclonal antibody against TGF-β1 in large animal experimental model of partial portal vein ligation.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12024113
- 003
- CZ-PrNML
- 005
- 20171213083734.0
- 007
- ta
- 008
- 120815s2012 gr f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.5754/hge10116 $2 doi
- 035 __
- $a (PubMed)22251543
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gr
- 100 1_
- $a Liska, Vaclav $u Department of Surgery, Charles University Medical School and Teaching Hospital, Pilsen, Czech Republic. Vena.Liska@seznam.cz
- 245 10
- $a Inhibition of transforming growth factor beta-1 augments liver regeneration after partial portal vein ligation in a porcine experimental model / $c V. Liska, V. Treska, H. Mirka, J. Kobr, R. Sykora, T. Skalicky, A. Sutnar, O. Vycital, J. Bruha, P. Pitule, A. Chlumska, J. Racek, J. Benes, L. Holubec,
- 520 9_
- $a BACKGROUND/AIMS: TGF-β1 is a pleiotropic cytokine that is over expressed in terminal phase of liver regeneration. METHODOLOGY: Twenty-four hours after partial portal vein ligation monoclonal antibody against TGF-β1 (TGF-β1 group, 7 piglets) or physiological solution (control group, 9 piglets) were applied into the central venous catheter. The biochemical parameters (bilirubin, urea, creatinine, alkaline phosphatase, gamma- glutamyl transferase, cholinesterase, aspartate aminotransferase, alanine aminotransferase and albumin) were assessed. The compensatory hypertrophy of the non-occluded liver lobes was evaluated by periodic ultrasonography during the next fourteen days and by histological examination. RESULTS: The acceleration of growth of the hypertrophic liver lobes was maximal between 3rd and 7th postoperative days in comparison with the control group (p<0.05). No important differences in the biochemical or studied histological parameters were proved. CONCLUSIONS: The present study describes a new usage of monoclonal antibody against TGF-β1 in large animal experimental model of partial portal vein ligation.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a novorozená zvířata $7 D000831
- 650 _2
- $a monoklonální protilátky $x farmakologie $7 D000911
- 650 _2
- $a biologické markery $x metabolismus $7 D015415
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a hypertrofie $7 D006984
- 650 _2
- $a ligace $7 D008026
- 650 _2
- $a játra $x krevní zásobení $x účinky léků $x metabolismus $x patologie $7 D008099
- 650 _2
- $a regenerace jater $x účinky léků $7 D008115
- 650 _2
- $a modely u zvířat $7 D023421
- 650 _2
- $a vena portae $x chirurgie $7 D011169
- 650 _2
- $a prasata $7 D013552
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a transformující růstový faktor beta1 $x antagonisté a inhibitory $x metabolismus $7 D053773
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Treska, Vladislav $u Department of Surgery, Charles University, Medical School and Teaching Hospital Plzen, Pilsen, Czech Republic
- 700 1_
- $a Mirka, Hynek $u Department of Radiology, Charles University, Medical School and Teaching Hospital Plzen, Pilsen, Czech Republic
- 700 1_
- $a Kobr, Jiri $u Department of Pediatrics, Charles University, Medical School and Teaching Hospital Plzen, Pilsen, Czech Republic
- 700 1_
- $a Sykora, Roman $u First Department of Medicine, Charles University, Medical School and Teaching Hospital Plzen, Pilsen, Czech Republic
- 700 1_
- $a Skalicky, Tomas $u Department of Surgery, Charles University, Medical School and Teaching Hospital Plzen, Pilsen, Czech Republic
- 700 1_
- $a Sutnar, Alan $u Department of Surgery, Charles University, Medical School and Teaching Hospital Plzen, Pilsen, Czech Republic
- 700 1_
- $a Vycital, Ondrej $u Department of Surgery, Charles University, Medical School and Teaching Hospital Plzen, Pilsen, Czech Republic
- 700 1_
- $a Bruha, Jan $u Department of Surgery, Charles University, Medical School and Teaching Hospital Plzen, Pilsen, Czech Republic
- 700 1_
- $a Pitule, Pavel $u Department of Surgery, Charles University, Medical School and Teaching Hospital Plzen, Pilsen, Czech Republic
- 700 1_
- $a Chlumska, Alena $u Institute of Pathology, Charles University, Medical School and Teaching Hospital Plzen, Pilsen, Czech Republic
- 700 1_
- $a Racek, Jaroslav $u Department of Biochemistry, Charles University, Medical School and Teaching Hospital Plzen, Pilsen, Czech Republic
- 700 1_
- $a Benes, Jan $u Department of Anaesthesiology, Charles University, Medical School and Teaching Hospital Plzen, Pilsen, Czech Republic
- 700 1_
- $a Holubec, Luboš, $d 1972- $7 xx0068645 $u Central Radioisotopic laboratory, Charles University, Medical School and Teaching Hospital Plzen, Pilsen, Czech Republic
- 773 0_
- $w MED00002025 $t Hepato-gastroenterology $x 0172-6390 $g Roč. 59, č. 113 (2012), s. 235-240
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/22251543 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120815 $b ABA008
- 991 __
- $a 20171213083922 $b ABA008
- 999 __
- $a ok $b bmc $g 946261 $s 781441
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 59 $c 113 $d 235-240 $i 0172-6390 $m Hepato-gastroenterology $n Hepatogastroenterology $x MED00002025
- GRA __
- $a NS9731 $p MZ0
- LZP __
- $a Pubmed-20120815/12/02